Transaction volume declined in Q1, reflecting a broad reduction in volume across most sectors, fewer platform transactions, and a modest dip in sponsor exits. In contrast to the downward trend in completed deals, investors and operators were very active in Q1, preparing and launching M&A processes. Provident expects a significant rebound in Q2 and Q3 activity, largely focused on high-quality assets, new platform formations, and sponsor exits. Gradually improving financing markets and significant equity dry powder will support near-term activity in deal processes with an increasing convergence of buyer and seller valuation expectations.
Read the full article: Provident Healthcare Partners Q1 2026 Market Update //
Source: https://www.providenthp.com/wp-content/uploads/2026/04/Q1-2026-Newsletter.pdf